Fortifying Angiogenesis in Ischemic Muscle with FGF9‐Loaded Electrospun Poly(Ester Amide) Fibers

Improving blood flow to ischemic limbs through therapeutic angiogenesis is an unrealized goal. The mural cell‐targeting factor, fibroblast growth factor 9, is delivered from electrospun poly(ester amide) nanofibers into ischemic muscles in mice. Sustained delivery of this factor fortifies the neo‐microvascular network, reduces fibrosis, and improves locomotion. This simple delivery system raises regenerative therapy prospects for managing peripheral vascular disease.

Abstract

Delivery of angiogenic growth factors lessens ischemia in preclinical models but has demonstrated little benefit in patients with peripheral vascular disease. Augmenting the wrapping of nascent microvessels by mural cells constitutes an alternative strategy to regenerating a functional microvasculature, particularly if integrated with a sustained delivery platform. Herein, electrospun poly(ester amide) (PEA) nanofiber mats are fabricated for delivering a mural cell‐targeting factor, fibroblast growth factor 9 (FGF9). Proof‐of‐principle is established by placing FGF9/FGF2‐loaded PEA fiber mats on the chick chorioallantoic membrane and identifying enhanced angiogenesis by 3D power Doppler micro‐ultrasound imaging. To assess the delivery system in ischemic muscle, FGF9‐loaded PEA fiber mats are implanted onto the surface of the tibialis anterior muscle of mice with hindlimb ischemia. The system supplies FGF9 into the tibialis anterior muscle and yields a neo‐microvascular network with enhanced mural cell coverage up to 28 days after injury. The regenerating muscle that receives FGF9 display near‐normal sized myofibers and reduced interstitial fibrosis. Moreover, the mice demonstrate improved locomotion. These findings of locally released FGF9 from PEA nanofibers raise prospects for a microvascular remodeling approach to improve muscle health in peripheral vascular disease.

https://ift.tt/2EmlqCT